Related Experiment Video
Updated: Jul 6, 2026

A Modified Technique for Inducing Polycystic Ovary Syndrome in Mice
Published on: July 5, 2024
A case of constrictive pericarditis during cabergoline treatment for hyperprolactinaemia
Magnus Löndahl1, Anders Nilsson, Hans Lindgren
1Department of Endocrinology, Lund University Hospital, S-221 85 Lund, Sweden. magnus.londahl@skane.se
Objective:
Treatment with dopamine agonists has been associated with cardiopulmonary fibrotic reactions, predominantly in patients treated for Parkinson's disease. To our knowledge, these reactions have previously not been associated with low-dose cabergoline treatment for hyperprolactinaemia.
Method:
A case of constrictive pericarditis in a patient treated with cabergoline for hyperprolactinaemia is presented. The patient has been treated at a county hospital and a university hospital in southern Sweden.
Results:
A 20-year-old woman with a 3-year history of amenorrhoea was referred to the department in 1992. From 2001 to 2005, she was given cabergoline, 0.5-1.5 mg/week. In 2005 a pericardectomy was performed due to fibrotic, constrictive pericarditis.
Conclusions:
Our present case suggests that constrictive pericarditis may develop even on low-dose cabergoline, which might indicate that this reaction, as opposed to valvular fibrosis, is not mediated by a 5-HT(2B) agonistic mechanism.
Related Concept Videos
Pericarditis III: Medical Management
Pericarditis IV: Nursing Management
Cushing Syndrome II: Pathophysiology
Pericarditis II: Clinical Features and Diagnostic Tests
Pericarditis I: Introduction
Cushing Syndrome I: Introduction